Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

ALS Phase III Clinical Trial Launched Using Stem Cells

Posted by [email protected] on Oct 2, 2017 4:45:00 PM

Phase III clinical trials for a stem cell based ALS treatment has been initiated.  ALS, or amyotrophic lateral sclerosis, is a disorder in which motor neurons in the body rapidly degenerate, and the treatment aims to prolong the survival rate of afflicted individuals by using autologous [the patient’s own] mesenchymal stem cells (the same stem cells found in teeth), which can be differentiated into fully-functioning neurons. The trials, to be conducted by BrainStorm Therapeutics, exploits the company’s proprietary technology [NurOwn], which utilizes mesenchymal stem cells. BrainStorm obtains these cells from the patient, expanding and differentiating the stem cells prior to application. The stem cells begin producing neurotrophic factors that facilitate neuronal growth and regeneration.

Read More

Topics: ALS, patient's own mesenchymal stem cells, stem cell treatments, regenerative medicine

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Posts by Topic

see all